Each one in plain English, with the numbers worked through for a shareholder.
20 Oct 2026quarterly activities report● Neutral
September 2026 quarter report restates the scoping study (NPV8 US$6.0bn, IRR 90%), pilot plant first concentrate and Sulista South discovery. Cash was A$122m with no borrowings at 30 September, down from A$135m at 30 June. Mostly previously announced.
New Sulista South discovery: stacked seams over 500m of strike, up to 18m true thickness and grades up to 13.3% TREO. Sulista East strike extended 430m beyond the current resource. Updated Sulista resource is targeted by end-2026, with 16 holes' assays pending.
ATO Class Ruling confirms the Alurion demerger qualifies for roll-over relief. Cost base splits 89.2% BRE and 10.8% Alurion; capital reduction was $0.1829 per share. Demerger completed 24 July, with Alurion trading from 31 July. Resolves the tax-treatment question for eligible holders.
Stage I pilot plant at Camaçari is commissioned and has produced its first rare earth concentrate. SENAI CIMATEC and partners will fund R$6.4m (~A$1.7m, ~59%) of the Stage II hydromet pilot, due to commission Q2 2027. Follows the Q3 2026 start-up expected earlier.
S&P Dow Jones Indices will add BRE to the S&P/ASX 300 from 21 September 2026. Alurion (ALU) is removed from the All Ordinaries in the same rebalance. An index inclusion notice, not a company announcement; no change to the business.
Half-year report to 30 June 2026 restates the 18 August Monte Alto + Camaçari scoping study, now showing after-tax NPV8 of about US$6bn, 90% IRR and 1.1-year payback. This replaces the retracted US$7.9bn figure. Extract is truncated, so no financial statements are visible.
About 10,000m of new Monte Alto drilling extends the deposit south and east/down dip, including 25.6m at 17.4% TREO (8m at 28.1%). None of it is in the current resource; an updated resource is targeted by end-2026, and a northern 1,400m program is planned.
Updated investor presentation for the revised Monte Alto + Camaçari scoping study issued 18 August. Extract shows cautionary statements, with the production target now ~75% Indicated and ~25% Inferred. No new figures visible.
BRE retracts the 13 August production target and all forecast financials (including the US$7.9bn NPV), saying too much Inferred resource in mine years 9-14 left no reasonable basis for them. It reissues a Monte Alto + Camaçari case excluding Sulista, ~75% Indicated, with ~US$969m funding needed.
Rocha da Rocha scoping study (Monte Alto-based) reports after-tax NPV8 of US$7.9bn, IRR 89%, payback 1.1 years, at Argus price forecasts. Monte Alto resource averages 11.3% TREO; cost about US$21/kg NdPr-equivalent. Preliminary study; it was retracted five days later (see 18 Aug).
Investor presentation summarising the Rocha da Rocha scoping study released the same day. Extract shows cautionary statements, including ±40% accuracy and a production target of ~44% Indicated and ~56% Inferred resources. No new figures beyond the main announcement.
June 2026 quarter recaps the Velhinhas 9km corridor, the yttrium-rich Monte Alto HREE+Y results, the 99.94% demerger vote and the A$50m Alurion IPO. Mostly previously announced items; no new results visible in the extract.
22 July 2026capital raising announcement▲ GoodMajor
Alurion's IPO closed at the A$50m maximum (47.6m shares at A$1.05) after BRE holders backed the demerger with 99.94% on 10 July. BRE keeps 39.0m Alurion shares (~16%, ~A$41m). Admission expected 30 July; BRE says its Monte Alto scoping study is due August.
What it means for a shareholder
47.6m new shares at A$1.05 to raise about A$50.0m. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
Six diamond holes (604m) at the Monte Alto HREE+Y Discovery, ~2.5km south of the main deposit, confirm yttrium-rich heavy rare earths in bedrock: 1.3m at 10.9% TREO with 5.8% Y2O3. BRE will now report its Monte Alto assets as one 'Monte Alto District'.
Supplementary prospectus for the Alurion IPO moves the priority offer opening to 22 June 2026 and adds disclosure that the Amargosa scoping study's US$119m capital cost is preliminary. Also adds NPV assumptions (US$71/t) and the 337.2Mt indicated / 230.6Mt inferred split of the 568Mt resource. Listing still expected 29 July.
Airborne survey defines over 9km of exploration trends at Velhinhas, starting ~5km south of Monte Alto. Surface samples reach 39.6% TREO; reconnaissance drilling returned 19.6% TREO. A 5,000m+ follow-up campaign with an extra rig is under way. Early-stage district growth.
Alurion investor presentation for the Amargosa spin-out. Text shown is only disclaimers and legal notices; no new results or figures are visible in the extract.
Short-form prospectus covers the in-specie distribution of 157,082,188 Alurion shares at ~0.5607 per BRE share. Conditional on shareholder approval of the capital reduction at the meeting. Formal document for the demerger already announced.
Alurion's IPO prospectus offers 28.6m-47.6m shares at A$1.05 to raise A$30-50m, with a priority offer to BRE shareholders. Conditional on listing conditions being met. Describes the shares as highly speculative. Repeats the terms announced in the demerger documents.
What it means for a shareholder
47.6m new shares at A$1.05 to raise about A$50.0m. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
BRE issues demerger documents; Alurion's IPO prospectus offers A$30-50m at A$1.05 per share. BRE shareholders vote 10 July 2026 on distributing 80.1% of Alurion pre-IPO (~0.5607 per BRE share). BRE retains ~16-17%, with ALU listing expected 29 July.
Alurion names Mauricio Noronha CEO and a board chaired by Thomas Todd. BRE's Todd Hannigan and Bernardo da Veiga join as executive directors. Gives the Amargosa spin-out its own leadership ahead of the proposed IPO and listing.
BRE will demerge 100%-owned Amargosa into Alurion Resources (proposed ASX: ALU), giving shareholders 0.5607 ALU shares per BRE share. Alurion plans a A$30-50m IPO; BRE keeps ~17-18% post-IPO. Firms up the mid-2026 de-merger flagged since December 2025.
March 2026 quarter recaps Monte Alto drilling (up to 35.3% TREO, 32,372m), ore sorting, 150°C acid cure, the Trial Mining Licence and Sulista's 17km strike. Maiden Monte Alto resource and scoping study now targeted mid-2026. Mostly previously reported results.
2025 annual report (year to 31 December 2025) recaps the year: Monte Alto expansion, ore sorting, 150°C acid cure, Amargosa scoping study, Carester partnership and A$120m raise. Cash and financial assets A$162.4m. Extract truncated, so no new financial detail visible.
Appendix 4G and corporate governance statement lodged with the 2025 annual report, confirming the board approved the statement as accurate at 30 March 2026. Administrative filing with no new business or financial information.
BRE granted a Trial Mining Licence for Monte Alto by Brazil's ANM, allowing up to 2,000 tonnes per year of product for customer samples and the Camaçari pilot plant. Pilot plant start is now Q3 2026; Economic Development Plan due to ANM in Q2 2026.